David Berman, M.D., Ph.D.

David Berman, M.D., Ph.D.

Former Executive Vice President, Head of Research & DevelopmentatImmunocore Holdings· In proxies 2023–2025

Pay in FY2025-22% from the year before · Immunocore Holdings stock +17.7% the same year

David Berman, M.D., Ph.D. was paid $4.3M in FY2025 (Dec), down 22%. Immunocore Holdings stock rose 17.7% that year.

Pay$100 in the stock at the end of FY22 → $61
Pay is from the Summary Compensation Table of each Immunocore Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Immunocore HoldingsPublic company · 3 yr
    • Former Executive Vice President, Head of Research & Development2023 – Present · 3 yrStock in role -42%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?